Showing 1081-1090 of 3009 results for "".
Five Malpractice and Medical Liability Risks Every Neurologist Should Know
https://practicalneurology.com/archives/aug-2026/five-malpractice-and-medical-liability-risks-every-neurologist-should-know/67240/Malpractice and medical liability remain significant concerns in neurology, but understanding common risk areas can help clinicians protect patients and their practices.Access to Newer AEDs and Specialists are Key to Seizure Control
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/access-to-newer-aeds-and-specialists-are-key-to-seizure-control/30541/A new report shows that some patients still lack access to care resources.Epilepsy Essentials: Neuromodulation Devices for Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-neuromodulation-devices-for-epilepsy/30165/Implantable devices are an emerging option for patients with medically refractory epilepsy who are not surgical candidates.Soft Skills for Challenging Times
https://practicalneurology.com/columns/practice-management/soft-skills-for-challenging-times/30399/An overview of skills practice administrators and other employees need in order to build a strong, successful team.Raising Urate With Inosine to Potentially Slow Progression of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-focus/30688/Results of the Phase II SURE-PD study show inosine is safe and tolerable and raises urate levels, which have been inversely related to Parkinson's progression. Still, patients are cautioned against self-medicating before the next phase of this research effort is completed.Movement Disorders Moment: Rapid Eye Movement Sleep Behavior Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-rapid-eye-movement-sleep-behavior-disorder/30117/This sleep disorder is a strong predictor for the development of synucleinopathies, including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies.Global Outcomes Data and Possible New Therapies in the Huntington's Pipeline
https://practicalneurology.com/diseases-diagnoses/movement-disorders/global-outcomes-data-and-possible-new-therapies-in-the-huntingtons-pipeline/30606/Researchers are focused on patient outcomes on a global scale and join clinicians in the vigil for new drug approvals.Special Report: 2023 Neurology Drug & Device Approvals
https://practicalneurology.com/diseases-diagnoses/imaging-testing/special-report-2023-neurology-drug-device-approvals/32081/A quick reference for the drugs and devices for neurologic conditions that received approval from the Food and Drug Administration last year.Resumption of Anticoagulant Therapy Following Ischemic and Hemorrhagic Strokes: Indications and Timing
https://practicalneurology.com/diseases-diagnoses/stroke/resumption-of-anticoagulant-therapy-following-ischemic-and-hemorrhagic-strokes-indications-and-timing/31965/Resumption of anticoagulant in ischemic stroke or intracranial hemorrhage should be individualized.Physical and Cognitive Activity for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/physical-and-cognitive-activity-for-dementia/31733/There is enough evidence of the neuroprotective effects of physical and cognitive activity to recommend these to patients.